This company listing is no longer active
A150840 Stock Overview
IntroMedic Co., Ltd. develops and supplies medical equipment in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
IntroMedic Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,850.00 |
| 52 Week High | ₩8,220.00 |
| 52 Week Low | ₩2,460.00 |
| Beta | 0.40 |
| 1 Month Change | 0% |
| 3 Month Change | -4.26% |
| 1 Year Change | 136.36% |
| 3 Year Change | 6.36% |
| 5 Year Change | 70.31% |
| Change since IPO | 105.26% |
Recent News & Updates
Shareholder Returns
| A150840 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | -1.9% |
| 1Y | 136.4% | -4.3% | -9.5% |
Return vs Industry: A150840 exceeded the KR Medical Equipment industry which returned 10.8% over the past year.
Return vs Market: A150840 exceeded the KR Market which returned 8% over the past year.
Price Volatility
| A150840 volatility | |
|---|---|
| A150840 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A150840 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine A150840's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 54 | Yong Seok Cho | www.intromedic.com |
IntroMedic Co., Ltd. develops and supplies medical equipment in South Korea and internationally. It offers MiroCam, a capsule endoscope system; E.G. Scan, a disposable ductile esophagoscope; and EndoClot, an absorbent hemostasis equipment.
IntroMedic Co., Ltd. Fundamentals Summary
| A150840 fundamental statistics | |
|---|---|
| Market cap | ₩223.67b |
| Earnings (TTM) | -₩15.52b |
| Revenue (TTM) | ₩8.01b |
27.9x
P/S Ratio-14.4x
P/E RatioIs A150840 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A150840 income statement (TTM) | |
|---|---|
| Revenue | ₩8.01b |
| Cost of Revenue | ₩3.43b |
| Gross Profit | ₩4.59b |
| Other Expenses | ₩20.11b |
| Earnings | -₩15.52b |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -405.99 |
| Gross Margin | 57.23% |
| Net Profit Margin | -193.75% |
| Debt/Equity Ratio | 16.3% |
How did A150840 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/06/11 19:45 |
| End of Day Share Price | 2022/03/14 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IntroMedic Co., Ltd. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jee Hyung Han | Korea Investment & Securities Co., Ltd. |